InsidersTradesSigma
Track the 카이바이오텍 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 카이바이오텍 has published 13 reports. The latest transaction was filed on 20 September 2024 (Purchase). Among the most active insiders: 케이비인베스트먼트. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
13 of 13 declarations
Kai Biotech is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for healthcare.